Skip to content

Advancing Public Health

Six healthcare professionals attend to a patient suffering from COVID-19 in an operating room setting

Vision

Johnson & Johnson Vision aims to help people see better, connect better, live better. We activate and advance innovations to protect, treat, cure and support every person’s lifelong journey of healthy sight. Across the world, we collaborate to expand access to quality eye care in communities with the greatest need.

Facts About Eye Health24

A girl looks into a mirror with a trial pair of eye glasses and smiles
By 2050, 4.8 billion people (half of the world’s population) are projected to be myopic.
Cataracts are the main cause of preventable blindness worldwide, affecting 100 million eyes.
T3-Vision-Eye-Icon.svg
Globally, at least 2.2 billion people have a vision impairment,
and of these, at least 1 billion people have a vision impairment that could have been prevented or is yet to be addressed.

Johnson & Johnson Vision continues to deliver new vision solutions from specialty lenses to innovative surgical equipment for the most advanced vision procedures. The shift to digital platforms has created a rapid increase in vision demands. To meet these needs, Johnson & Johnson Vision developed its most advanced intraocular lens (IOL) using its TECNIS platform, a proprietary combination of materials and design for IOLs that was pioneered 20 years ago. The TECNIS SYNERGY is a presbyopia-correcting IOL that combines the best of extended depth-of-focus and multifocal technologies to deliver the widest range of continuous vision without the visual gaps caused by existing multifocal technology. For example, ACUVUE THERAVISION with Ketotifen contact lenses, which were approved and launched in Canada and Japan in 2021, and in the U.S. in 2022, are the world’s first and only drug-releasing contact lenses for vision correction and allergic eye itch. For cataracts, we have developed the broadest global portfolio of intraocular lenses to offer patients continued freedom from wearing glasses.

At Johnson & Johnson Vision, we have a bold ambition to redefine healthy sight for life. People value sight above all other senses—it’s how we learn and how we connect. Yet, two billion people right now are living with vision impairment—more than half of which could have been prevented or has yet to be treated. This is what motivates our teams around the world every day. Together, we’re protecting sight, optimizing sight, restoring sight.
Peter Menziuso
Company Group Chairman, Johnson & Johnson Vision

Beyond product innovation (see section: Innovation in Practice), examples of our activities to advance eye health and care in 2021 included:

Contact lenses for managing myopia: In 2021, the FDA FDA U.S. Food and Drug Administration approved ACUVUE ABILITI Overnight Therapeutic Lenses, the first and only FDA-approved orthokeratology contact lens for managing myopia. The approval is the result of a collaboration between Johnson & Johnson Vision and Menicon and represents a breakthrough in helping patients and eye care professionals address the progression of myopia.

Addressing unmet needs in cataract surgery: We expanded the availability of our next-generation cataract surgery globally, offering more surgeons, patients and healthcare systems around the world the possibility of better health outcomes. The VERITAS Vision System is an advanced phacoemulsification (phaco) system designed to address three critical areas of cataract surgery: patient safety, surgeon efficiency and comfort. Phacoemulsification is the most common cataract surgery technique25 and allows surgeons to effectively emulsify and efficiently remove the eye’s internal lens when it has become cloudy from cataracts. The equipment that surgeons can rely on in performing the procedure is critical to optimizing the circumstances for surgical success.

New integrated eye health ecosystem in Singapore: In line with Singapore’s Smart Nation initiative, Johnson & Johnson Vision established a three-year roadmap of initiatives designed to establish Singapore as the regional hub for eye health innovation, supported by our expected investment of SGD 10 million over three years. Rooted in a new, integrated eye health ecosystem, our efforts will support the delivery of a new standard of eye care by improving access, capacity and personalization of patient care. Further, with a focus on data and digitalization, this initiative aims to foster up to 40 local eye care professionals in leadership positions with the support of the Singapore Economic Development Board.

Learn more

Ecosystem's Key Initiatives

Misc-T3-Vision-Graphic1-Module13-A.svg
Misc-T3-Vision-Graphic2-Module13-B.svg
Misc-T3-Vision-Graphic3-Module13-C.svg

Ecosystem's Key Initiatives

EDB supports Johnson & Johnson Vision’s commitment to pioneer an integrated eye health ecosystem and elevate the standard of care for eye health. This project provides exciting job opportunities in Singapore for digital talent and reinforces Singapore’s position as a leading innovation hub for digital health.
Ms Goh Wan Yee
Senior Vice President and Head, Healthcare, Economic Development Board

Working with global partners to improve eye care access and quality: Longstanding strategic partners that we engage with to advance our mission to change the trajectory of eye health include:

  • HCP Cure Blindness: Dedicated to reaching the most unreachable patients, HCP Cure Blindness envisions a world in which no person is needlessly blind. The organization cultivates the growth of local, sustainable eye care systems and outreach
    events to ensure access for all to high-quality, cost-effective care in underserved areas of the world. Johnson & Johnson Vision supports its efforts to bring life-changing care to more than 20 countries across South Asia and sub-Saharan Africa. In June 2021, in honor of World Cataract Day, Johnson & Johnson Vision teams led a company-wide campaign to raise awareness and funds for HCP Cure Blindness to help reach more people affected by blindness and lack of access to care.
Dr. Reeta Gurung lays his hand over the eye of a patient in Eritrea.

Dr. Reeta Gurung, CEO of the Tilganga Institute of Ophthamology, at HCP’s surgical outreach in Eritrea. Photo by Chris Briscoe.

  • Sight for Kids (SFK): Since 2002, Lions Clubs International Foundation has collaborated with Johnson & Johnson Vision to implement the largest-known, school-based eye health program, SFK. This innovative program mobilizes eye care professionals and volunteers to provide comprehensive eye health services to students in low-income schools across North America, Asia and Africa. In 2021, SFK was expanded to the U.S., in collaboration with the Florida Heiken Children’s Vision program (a division of Miami Lighthouse for the Blind and Visually Impaired), to bring comprehensive eye health services and treatments to approximately 20,000 South Florida students experiencing inequities in access to eye health care.26 In addition to pro bono eye exams and eyeglasses provided in compliance with COVID-19 safety guidance from the CDC CDC Centers for Disease Control and Prevention and the American Optometric Association, program participants will also receive educational eye health materials, available in four languages to meet the needs of these diverse communities.

Learn more about social responsibility at Johnson & Johnson Vision

Previous Mental Healthcare Next Consumer Health
Back to Top